Tafamidis Meglumine

CAS 951395-08-7 13 current records 1 historicalSmall Molecule

Who holds supplier records for Tafamidis Meglumine? 13 organisations hold a current record for Tafamidis Meglumine: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (11) and United States (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Tafamidis Meglumine: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/tafamidis-meglumine

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    11 of the 12 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tafamidis Meglumine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India11United States1Country not recorded for 1
Need Tafamidis Meglumine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Tafamidis Meglumine are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • Czechia · Inactive DMF 38912 · filed Sept 2023

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Tafamidis Meglumine is a chaperone amyloid fibril inhibitor used for the treatment of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and transthyretin-related hereditary amyloid polyneuropathy (hATTR-PN). It stabilizes transthyretin, thus preventing the misfolding and deposition of amyloid fibrils in tissues.

Chemical identity

IUPAC name
2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
Canonical SMILES
CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl
InChIKey
DQJDBUPLRMRBAB-WZTVWXICSA-N
Synonyms
Vyndaqel API, fx-1006a, vyndaqel

Therapeutic areas

NeurologyCardiology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tafamidis Meglumine?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Tafamidis Meglumine: ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), Aurore Life Sciences (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Dr. Reddy's Laboratories Ltd. (India), HONOUR LAB LTD (India), HUNAN OUYA PHARMACEUTICAL CO LTD and MSN Laboratories Private Limited (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Tafamidis Meglumine Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 37026), APITORIA PHARMA PRIVATE LTD (DMF 37492), Aurore Life Sciences (DMF 37152), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 37205), Dr. Reddy's Laboratories Ltd. (DMF 37979), HONOUR LAB LTD (DMF 38304), HUNAN OUYA PHARMACEUTICAL CO LTD (DMF 40980) and MSN Laboratories Private Limited (DMF 34696) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Tafamidis Meglumine records mean?

1 organisation has only inactive Type II DMFs for Tafamidis Meglumine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Tafamidis Meglumine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tafamidis Meglumine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.